Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Stem Cell and Regenerative Medicine Institute, Samsung Medical Center, Seoul, Korea.
PLoS One. 2019 Aug 30;14(8):e0221847. doi: 10.1371/journal.pone.0221847. eCollection 2019.
To determine the effects of antenatal betamethasone and/or postnatal dexamethasone administration on hyperoxic lung and brain injuries in newborn rats.
Newborn Sprague-Dawley rats were divided into five experimental groups: normoxia-vehicle-vehicle group, hyperoxia-vehicle-vehicle group, hyperoxia-betamethasone-vehicle group, hyperoxia-vehicle-dexamethasone group, and hyperoxia-betamethasone-dexamethasone group according to (i) whether rats were exposed to normoxia or hyperoxia after birth to postnatal day (P) 14, (ii) whether antenatal betamethasone (0.2mg/kg) or vehicle was administered to pregnant rats at gestation days 19 and 20, and (iii) whether three tapering doses of dexamethasone (0.5, 0.3, 0.1mg/kg per day) or vehicle were administered on P5, 6 and 7, respectively. The lungs and brains were harvested for histological and biochemical analyses at P8 and P14.
Postnatal dexamethasone but not antenatal betamethasone significantly enhanced hyperoxia-induced reduction in body weight gain and alveolarization and increased lung terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells both at P8 and P14, transiently increased hyperoxia-induced reductions in brain weight gain and angiogenesis, and increase in brain TUNEL-positive cells at P8 but not at P14. Co-administration of antenatal betamethasone significantly enhanced dexamethasone-induced impairments in alveolarization both at P8 and P14, transient increases in lung and brain oxidative stresses, and increases in brain TUNEL-positive cells at P8 but not at P14.
Although postnatal dexamethasone but not antenatal betamethasone alone significantly increased hyperoxic lung and brain injuries, co-administration of antenatal betamethasone significantly enhanced the detrimental effects of postnatal dexamethasone on hyperoxic lung and brain injuries in newborn rats.
确定产前倍他米松和/或产后地塞米松给药对新生大鼠高氧肺和脑损伤的影响。
根据(i)出生后新生 Sprague-Dawley 大鼠是暴露于常氧还是高氧至生后第 14 天,(ii)是否在妊娠第 19 和 20 天对妊娠大鼠给予产前倍他米松(0.2mg/kg)或载体,以及(iii)是否在生后第 5、6 和 7 天给予三次递减剂量的地塞米松(0.5、0.3、0.1mg/kg/天)或载体,将新生大鼠分为五个实验组:常氧-载体-载体组、高氧-载体-载体组、高氧-倍他米松-载体组、高氧-载体-地塞米松组和高氧-倍他米松-地塞米松组。在生后第 8 天和第 14 天采集肺和脑进行组织学和生化分析。
产后地塞米松而非产前倍他米松显著增强了高氧诱导的体重增加和肺泡化减少,并增加了肺末端脱氧核苷酸转移酶 dUTP 缺口末端标记(TUNEL)阳性细胞,在生后第 8 天和第 14 天均有此作用,短暂增加了高氧诱导的脑重增加和血管生成减少,并增加了脑 TUNEL 阳性细胞,仅在生后第 8 天。产前倍他米松联合应用显著增强了地塞米松诱导的肺泡化受损,在生后第 8 天和第 14 天均有此作用,短暂增加了肺和脑的氧化应激,并增加了脑 TUNEL 阳性细胞,仅在生后第 8 天。
尽管产后地塞米松而非产前倍他米松单独使用显著增加了高氧肺和脑损伤,但产前倍他米松联合应用显著增强了产后地塞米松对新生大鼠高氧肺和脑损伤的有害作用。